CT/NGS-CRO/TV/MGS-AZM
- Chlamydia trachomatis (CT)
- Neisseria gonorrhoeae (NG)
- Trichomonas vaginalis (TV)
- Mycoplasma genitalium (MG)
- Ceftriaxone-susceptible Neisseria gonorrhoeae (NGS-CRO)
- Azithromycin-susceptible Mycoplasma genitalium (MGS-AZM)
Lesion Panel
- Mpox
- Syphilis
- Herpes simplex virus 1
- Herpes simplex virus 2
- Varicella-zoster virus
- Lymphogranuloma venereum
- Haemophilus ducreyi
UTI Panel
- Escherichia coli
- Klebsiella pneumoniae
- Proteus mirabilis
- Staphylococcus saprophyticus
- Enterococcus faecalis
- Pseudomonas aeruginosa
- Group B Streptococcus
- Providencia species (complicated UTI, HAI, and elderly males)
- ESBLs
- Carbapenemases
- AmpC beta-lactamases
- Fluoroquinolone resistance genes
- VanA & VanB
- mecA gene
- Pbpa
- penA
- penB
- MBLs
HPV Panel
- High-risk HPV types
16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68
The MagIC MagChipR and MagChip have not been approved or cleared by the U.S. Food and Drug Administration or any other regulatory authority. The performance characteristics of these devices have not been established.
